ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Eisai at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Eisai takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8067. Its program centres on kidney cancer and the choice of first-line treatment. It looks at how the treatment landscape for renal cell carcinoma keeps changing.
| Organization | ESMO 2026 Attendance |
|---|---|
Eisai Tokyo, Japan | |
Japanese pharmaceutical company whose oncology medicines include lenvatinib and eribulin. | Booth Exhibiting at Booth 8067 Satellite Fri Oct 23 09:45–11:15 Eisai - RCC in Motion: First-Line Choice and the Evolving RCC Treatment Landscape Genitourinary cancers |
Find decision makers at Eisai
Tell us what you sell and we’ll find the people at Eisai most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction